Welcome to our deep‑dive into the world of 10 astonishing medical breakthroughs that emerged in 2017, a year that proved science can be as daring as it is compassionate. From womb‑like chambers that nurture the tiniest of lives to tiny glowing particles that hunt down hidden cancers, each discovery pushes the boundaries of what medicine can achieve.
10 Astonishing Medical Highlights of 2017
10 Successful Artificial Womb
Scientists have engineered a groundbreaking artificial womb that can sustain extremely premature fetuses for about a month, mimicking the natural environment of a mother’s uterus. In a pioneering experiment, eight fetal lambs were delicately removed from their mothers far earlier than normal and placed into this synthetic womb, where they continued to grow and mature until they were gently “delivered” after four weeks.
The device consists of a transparent plastic enclosure filled with a specially formulated synthetic amniotic fluid. The fetus’s umbilical cord is linked to a sophisticated machine that supplies oxygen and nutrition directly to the blood, essentially replicating the placenta’s life‑supporting role.
Typical human gestation lasts roughly 40 weeks, yet thousands of babies worldwide are born before 26 weeks each year, and only about half survive. Those who do often endure severe complications such as cerebral palsy, paralysis, or profound developmental delays. An approved artificial womb could extend the developmental window for these infants, dramatically improving survival rates and long‑term outcomes.
Researchers anticipate that, within the next five years, the technology could be ready for carefully controlled human trials, offering a lifeline for the most vulnerable newborns and potentially reshaping neonatal care forever.
9 Pig Hybrid
In a remarkable feat of bioengineering, researchers succeeded in creating a human‑pig hybrid, scientifically known as a chimera—an organism containing cells from two distinct species. This achievement marks a pivotal step toward growing human organs inside animal hosts.
Two primary strategies exist for generating chimeras: transplanting a fully formed organ from one species into another, which carries a high risk of rejection, or introducing donor cells at the embryonic stage, allowing both cell types to develop together from the outset.
Early experiments demonstrated that rat cells could integrate and thrive within mouse embryos, leading to the formation of functional rat organs such as pancreas, eyes, and heart inside the mouse host. Building on this success, scientists turned to human cells, injecting them into early‑stage pig embryos.
Pigs were chosen because their organ size and physiology closely resemble those of humans, making them ideal candidates for xenotransplantation. After implantation into surrogate sows, the hybrid embryos were allowed to develop through the first trimester before being harvested for analysis. The study yielded 186 chimeric embryos, each displaying the early formation of essential human‑derived organs like the heart and liver.
This breakthrough brings the vision of lab‑grown human organs within reach, offering hope for the thousands of patients who die each day awaiting transplants. If perfected, such technology could alleviate organ shortages and transform transplant medicine.
8 Flu‑Fighting Frog Slime
A newly discovered frog species from southern India produces a remarkable slime on its skin that can neutralize influenza viruses. The slime is rich in short chains of amino acids, known as peptides, which serve as a natural defense against bacterial invaders. When scientists isolated these peptides, one in particular—named urumin—demonstrated potent activity against the flu.
Influenza viruses are characterized by two surface proteins: hemagglutinin (H) and neuraminidase (N). These proteins define the virus’s subtype; for instance, H1N1 combines the H1 version of hemagglutinin with the N1 version of neuraminidase. The hemagglutinin component is crucial for the virus to bind to host cells.
Urumin specifically targets the H1 hemagglutinin, effectively destroying every H1‑type flu strain tested, even those that have developed resistance to existing antiviral drugs. This broad‑spectrum activity suggests a promising pathway toward a universal flu vaccine.
Current flu medications mainly inhibit neuraminidase, a protein that mutates more frequently, limiting their long‑term efficacy. By focusing on hemagglutinin, urumin offers a novel mechanism that could lead to more durable, wide‑ranging protection against seasonal and pandemic influenza.
7 New Melanoma Treatment
A research team at Michigan State University has uncovered a promising new drug candidate that could dramatically cut mortality from melanoma, the deadliest form of skin cancer. Melanoma’s lethality stems from its ability to metastasize quickly, spreading to vital organs such as the lungs and brain.
The malignancy’s aggressive spread is driven by a transcriptional cascade in which cancer cells produce specific RNA molecules and proteins that facilitate invasion. The novel compound discovered by the team interrupts this transcriptional process, effectively halting the tumor’s ability to disseminate.
Laboratory tests revealed that the drug reduced melanoma cell spread by an impressive 90 percent. While still years away from human trials, the findings fuel optimism that this therapy could become a powerful weapon not only against melanoma but also against other cancers that rely on similar transcriptional mechanisms.
6 Bad Memory Eraser
Individuals plagued by post‑traumatic stress disorder or other trauma‑related anxieties may soon have a way to selectively erase the painful memories that haunt them. Decades of research into the brain’s memory pathways have culminated in a breakthrough by scientists at the University of California‑Riverside.
These researchers focused on the neural circuits that encode memories. When a traumatic event occurs, the associated neural pathway becomes unusually strong, allowing vivid recollection of the incident while more mundane memories fade. This imbalance explains why a single terrifying experience can dominate one’s mind for years.
In a series of experiments, the team paired a high‑pitched tone with a mild electric shock in mice, creating a fear memory that caused the animals to freeze whenever the sound played again. Using optogenetics—a technique that employs light to control genetically engineered neurons—the scientists weakened the connections within the fear‑related pathway.
After the optogenetic intervention, the mice were re‑exposed to the tone but exhibited no freezing behavior, indicating that the traumatic memory had been effectively suppressed. Crucially, the manipulation was precise: only the targeted fear memory was altered, leaving other cognitive functions, such as the ability to tie shoes, untouched.
This level of specificity suggests a future where patients could erase debilitating memories without compromising overall brain health, opening a new therapeutic frontier for mental health disorders.
5 Spider Venom Stroke Treatments
While the venom of the Australian Darling Downs funnel‑web spider is notorious for causing rapid death in humans, scientists have uncovered a hidden treasure within that toxic cocktail: a molecule named Hi1a that can shield brain cells from the devastation of stroke.
During a stroke, blood flow to parts of the brain is abruptly halted, depriving neurons of oxygen and leading to the buildup of acidic by‑products that kill cells. Existing treatments focus on dissolving clots or controlling bleeding but do nothing to directly protect neurons from damage.
Hi1a, isolated from the spider’s venom, has demonstrated powerful neuroprotective properties. In rat models, administering Hi1a two hours after inducing a stroke reduced brain damage by about 80 percent. Even when treatment was delayed to eight hours post‑stroke, damage was still cut by roughly 65 percent compared to untreated controls.
Because there are currently no drugs that can reverse the cellular injury caused by strokes, Hi1a represents a potential paradigm shift. Should human trials confirm its efficacy, stroke victims could receive a therapeutic that not only stabilizes them but also preserves brain tissue, dramatically improving recovery outcomes.
4 Human Trials Of Anti‑aging Treatment
An innovative anti‑aging therapy is edging closer to market approval after impressive animal studies demonstrated its ability to rejuvenate cellular function. The treatment centers on boosting levels of NAD+, a vital metabolite present in every cell that fuels DNA repair and other essential processes.
Researchers at the University of New South Wales administered nicotinamide mononucleotide (NMN), a direct precursor to NAD+, to elderly mice. Within just one week, the treated mice exhibited cellular repair capabilities comparable to those of much younger counterparts.
To further stress the system, the scientists exposed the mice to radiation—a known accelerator of cellular aging. Mice that received NMN before radiation showed markedly lower DNA damage, while those treated after exposure still benefited from reduced injury, underscoring NMN’s protective qualities.
Beyond extending healthy lifespan, such a therapy could aid populations exposed to heightened radiation, including astronauts on long‑duration missions, frequent flyers, and cancer survivors who often experience premature aging. By restoring the body’s innate repair mechanisms, NMN may become a cornerstone of future longevity medicine.
3 Early Detection Cancer Tracking
Scientists at Rutgers University have pioneered a cutting‑edge technique for spotting micrometastases—tiny, otherwise undetectable tumor clusters—by deploying microscopic “glow sticks” into the bloodstream. These nanoscopic particles emit short‑wave infrared light and are engineered to latch onto cancer cells as they circulate.
In early animal trials, the nanoparticles successfully homed in on breast cancer cells that had migrated to the legs and adrenal glands of mice. The infrared signal allowed researchers to visualize these minuscule tumors long before conventional imaging methods, such as MRI, could detect them.
This technology promises to identify cancers months ahead of standard screenings, offering a crucial window for early intervention. Researchers anticipate that, within the next five years, the method could be adapted for human clinical use, potentially revolutionizing cancer diagnostics and improving survival rates.
2 A Cure For The Common Cold
For centuries, humanity has chased an elusive remedy for the common cold, a pervasive ailment that has stubbornly resisted cures. Ancient Egyptian texts even prescribed a bizarre concoction involving the milk of a mother who had birthed a male child combined with fragrant gum, illustrating the long‑standing desperation to defeat this virus.
Modern over‑the‑counter remedies—vitamin C, Echinacea, and various antihistamines—provide only symptomatic relief and do not eradicate the underlying infection. The principal culprit behind most colds is the rhinovirus, responsible for roughly 75 % of cases.
Researchers at Edinburgh Napier University have made a promising breakthrough by synthesizing antimicrobial peptides derived from pigs and sheep. When these peptides were applied to lung cells infected with rhinovirus, they effectively neutralized the virus, opening the door to a potential cure.
The team is now refining the peptide structures to boost their potency and stability, with the goal of developing a drug that could finally halt the common cold at its source, rather than merely easing its symptoms.
1 Embryonic DNA Repair
In a landmark achievement, scientists have successfully edited the DNA of human embryos without introducing unintended harmful mutations. An international consortium employed a sophisticated gene‑editing platform to correct a mutation linked to cardiomyopathy, a serious heart disorder that can cause irregular beats, valve defects, and eventual heart failure.
The process began by harvesting sperm carrying the disease‑causing mutation and using it to fertilize donor eggs. Once the embryos formed, the researchers applied the editing tool to precisely excise the faulty gene segment.
This precise cut triggered the embryo’s natural DNA‑repair mechanisms, allowing it to mend the defect using its own template. Out of 58 embryos treated, 70 % showed successful correction of the mutation, and crucially, no off‑target alterations were detected—addressing a major concern from earlier attempts.
While these embryos were not implanted to develop into babies, the study represents a vital step toward preventing inherited genetic diseases. Future work will focus on safety, efficacy, and ethical considerations before any clinical application.
Critics caution that editing germline DNA could have far‑reaching consequences, as any mistakes would be passed down through generations, potentially spawning new genetic disorders. There are also fears of “designer babies,” where parents might select traits beyond disease prevention. However, researchers emphasize that their aim is strictly therapeutic—to eradicate conditions such as Huntington’s disease, cystic fibrosis, and BRCA‑related cancers—not to create customizable offspring.
As the field advances, balanced dialogue between scientists, ethicists, and the public will be essential to ensure that this powerful technology serves humanity responsibly.